EVGN · Forms 3, 4, 5
Insider trades at Evogene Ltd.
1 insider bought $692K of Evogene Ltd. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Evogene Ltd. (EVGN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Leon Recanati | Director | Options or other derivatives | Form 4 | ||||
| Nir Nimrodi | Director | Options or other derivatives | Form 4 | ||||
| Adrian John Percy | Director | Options or other derivatives | Form 4 | ||||
| Dan Michael Falk | Director | Options or other derivatives | Form 4 | ||||
| Leon Recanati | Director | Buy | 460,000 | $0.64 | $292K | Form 4 | |
| Leon Recanati | Director | Buy | 800,000 | $0.50 | $400K | Form 4 | |
| Gabi Tarcic | Chief Development Officer | Buy | 1,129 | $0.60 | $677 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.